{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T15:08:04Z","timestamp":1788188884725,"version":"build-2803163510"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T00:00:00Z","timestamp":1665532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Familial Hypercholesterolemia (FH) is one of the most common genetic disorders, with an estimated global prevalence of 1:200-500, which leads to premature cardiovascular disease. Nevertheless, public and professional awareness of FH is often lacking, with an estimated 20,000 largely undiagnosed cases in Ireland.<\/jats:p><\/jats:sec><jats:sec><jats:title>Purpose<\/jats:title><jats:p>The overall aim of the project was to test the feasibility of a model of care that would include electronic record screening, clinical assessment, and coding of possible FH patients across a network of general practices in Ireland. In addition, a secondary aim was to gauge the awareness and knowledge of FH across the network.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study took part in multiple phases, employing a mixed methods design. The study included a validated questionnaire, tailored online educational resources, a retrospective chart review of patients with a history of elevated LDL cholesterol (LDLc) and an active review with a selection of those patients. Results were analyzed using SPSS V27, where descriptive statistics and relevant correlation tests were employed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Eighteen general practices agreed to take part in the study. In the initial survey, respondents rated their personal and practice familiarity with FH as slightly below average. Around one-third of respondents were not aware of FH guidelines. Of over 55,000 adult patient records searched, only 0.2% had a recorded FH diagnosis and 3.9% had ever had an LDLc above 4.9 mmol\/l. Eight practices completed 198 chart reviews. Among these, 29.8% of patients had a family history recorded, and 22.2% had a family history of CVD recorded. Female patients had higher averages for highest and recent LDLc. Seventy patients underwent a clinical review\u2014with 27% of these patients identified as \u201cprobable\u201d or \u201cdefinite FH.\u201d There was a statistically significant (<jats:italic>p<\/jats:italic> = 0.002) relationship between FH status and whether the patient had other CVD risk factors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>General practitioners in Ireland had similar levels of awareness of FH compared to findings from elsewhere. The activities discussed encouraged clinicians to consider FH when talking to their patients, especially those with elevated LDLc at an early age. Broader awareness of the condition could increase conversations about FH and benefit patient outcomes.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.1016198","type":"journal-article","created":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T05:44:42Z","timestamp":1665553482000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["A mixed methods study of the awareness and management of familial hypercholesterolaemia in Irish general practice"],"prefix":"10.3389","volume":"9","author":[{"given":"Robyn","family":"Homeniuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.atherosclerosis.2018.06.855","article-title":"Epidemiology of familial hypercholesterolaemia: community and clinical","volume":"277","author":"Vallejo-Vaz","year":"2018","journal-title":"Atherosclerosis."},{"key":"B2","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease Consensus Statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.atherosclerosis.2018.08.019","article-title":"Screening for familial hypercholesterolaemia in primary care: time for general practice to play its part","volume":"277","author":"Brett","year":"2018","journal-title":"Atherosclerosis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1136\/bmjopen-2017-016461","article-title":"Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis","volume":"7","author":"Akioyamen","year":"2017","journal-title":"BMJ Open"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1161\/ATVBAHA.120.315904","article-title":"Large-Scale screening for monogenic and clinically defined familial hypercholesterolemia in iceland","volume":"41","author":"Bj\u00f6rnsson","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1161\/ATVBAHA.121.316862","article-title":"What is the prevalence of familial hypercholesterolemia?","volume":"41","author":"Brunham","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.atherosclerosis.2018.06.858","article-title":"Universal screening for familial hypercholesterolemia in children: the Slovenian model and literature review","volume":"277","author":"Groselj","year":"2018","journal-title":"Atherosclerosis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3399\/bjgpopen20X101142","article-title":"Screening for potential familial hypercholesterolaemia in general practice: an observational study on prevalence and management","volume":"5","author":"M\u00fclverstedt","year":"2021","journal-title":"BJGP Open."},{"key":"B9","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.atherosclerosis.2018.08.010","article-title":"High burden of recurrent cardiovascular events in heterozygous familial hypercholesterolemia: the French Familial Hypercholesterolemia Registry","volume":"277","author":"B\u00e9liard","year":"2018","journal-title":"Atherosclerosis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1136\/bmj.a1095","article-title":"Familial hypercholesterolaemia: summary of NICE guidance","volume":"337","author":"Wierzbicki","year":"2008","journal-title":"BMJ."},{"key":"B11","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1136\/bmj.303.6807.893","article-title":"Scientific steering committee on behalf of the simon broome register group","volume":"303","year":"1991","journal-title":"BMJ Br Med J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/S2213-8587(16)30041-9","article-title":"Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel","volume":"4","author":"Santos","year":"2016","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.jacc.2018.05.044","article-title":"Clinical genetic testing for familial hypercholesterolemia: JACC scientific expert panel","volume":"72","author":"Sturm","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"B14","unstructured":"Familial Hypercholesterolaemia. Irish Heart Foundation2022"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12875-021-01377-0","article-title":"How many general practice consultations occur in Ireland annually? Cross-sectional data from a survey of general practices","volume":"22","author":"Collins","year":"2021","journal-title":"BMC Fam Pract."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.hlc.2014.07.062","article-title":"Optimising the detection and management of familial hypercholesterolaemia: central role of primary care and its integration with specialist services","volume":"23","author":"Vickery","year":"2014","journal-title":"Hear Lung Circ."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1136\/openhrt-2021-001752","article-title":"Comparing the performance of the novel FAMCAT algorithms and established case-finding criteria for familial hypercholesterolaemia in primary care","volume":"8","author":"Qureshi","year":"2021","journal-title":"Open Hear"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1136\/heartjnl-2020-318813","article-title":"Improving detection and management of familial hypercholesterolaemia in Australian general practice","volume":"107","author":"Brett","year":"2021","journal-title":"Heart."},{"key":"B19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.atherosclerosissup.2017.07.004","article-title":"Detection of familial hypercholesterolemia in patients from a general practice database","volume":"29","author":"Casula","year":"2017","journal-title":"Atheroscler Suppl."},{"key":"B20","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.hlc.2013.08.005","article-title":"Familial hypercholesterolaemia in primary care: knowledge and practices among general practitioners in western Australia","volume":"23","author":"Bell","year":"2014","journal-title":"Hear Lung Circ."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e017817","DOI":"10.1136\/bmjopen-2017-017817","article-title":"An enquiry based on a standardised questionnaire into knowledge, awareness and preferences concerning the care of familial hypercholesterolaemia among primary care physicians in the Asia-Pacific region: the \u201cTen Countries Study\u201d","volume":"7","author":"Pang","year":"2017","journal-title":"BMJ Open."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-020-01845-y","article-title":"Validity and reliability of an adapted questionnaire measuring knowledge, awareness and practice regarding familial hypercholesterolaemia among primary care physicians in Malaysia","volume":"21","author":"Azraii","year":"2021","journal-title":"BMC Cardiovasc Disord."},{"key":"B23","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.atherosclerosis.2018.04.037","article-title":"Improving identification and management of familial hypercholesterolaemia in primary care: pre- and post-intervention study","volume":"274","author":"Weng","year":"2018","journal-title":"Atherosclerosis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.cjco.2019.05.001","article-title":"Awareness of familial hypercholesterolemia among healthcare providers involved in the management of acute coronary syndrome in victoria, Australia","volume":"1","author":"Mirzaee","year":"2019","journal-title":"CJC Open."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e012691","DOI":"10.1136\/bmjopen-2016-012691","article-title":"An online questionnaire survey of UK general practitioners' knowledge and management of familial hypercholesterolaemia","volume":"6","author":"Kwok","year":"2016","journal-title":"BMJ Open."},{"key":"B26","doi-asserted-by":"publisher","first-page":"891","DOI":"10.5551\/jat.35949","article-title":"Translational research for improving the care of familial hypercholesterolemia: the \u201cten countries study\u201d and beyond","volume":"23","author":"Watts","year":"2016","journal-title":"J Atheroscler Thromb."},{"key":"B27","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.atherosclerosis.2010.09.014","article-title":"Physicians' perception, knowledge and awareness of cardiovascular risk factors and adherence to prevention guidelines: the PERCRO-DOC survey","volume":"213","author":"Reiner","year":"2010","journal-title":"Atherosclerosis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.jacl.2022.04.001","article-title":"Applying an LDL-C threshold-based approach to identify individuals with familial hypercholesterolemia","volume":"16","author":"Jasani","year":"2022","journal-title":"J Clin Lipidol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41746-019-0101-5","article-title":"Finding missed cases of familial hypercholesterolemia in health systems using machine learning","volume":"21","author":"Banda","year":"2019","journal-title":"NPJ Digit Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41746-020-00349-5","article-title":"Performance and clinical utility of supervised machine-learning approaches in detecting familial hypercholesterolaemia in primary care","volume":"3","author":"Akyea","year":"2020","journal-title":"npj Digit Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3399\/bjgpopen20X101114","article-title":"Evaluating a clinical tool (FAMCAT) for identifying familial hypercholesterolaemia in primary care: a retrospective cohort study","volume":"4","author":"Akyea","year":"2020","journal-title":"BJGP Open."},{"key":"B32","unstructured":"2019"},{"key":"B33","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.ypmed.2010.09.015","article-title":"Public perceptions of cardiovascular risk factors in Croatia: the PERCRO survey","volume":"51","author":"Reiner","year":"2010","journal-title":"Prev Med (Baltim)."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1093\/eurheartj\/ehac224","article-title":"Screening in children for familial hypercholesterolaemia: start now","volume":"43","author":"Groselj","year":"2022","journal-title":"Eur Heart J."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1016198\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T05:44:47Z","timestamp":1665553487000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1016198\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,12]]},"references-count":34,"alternative-id":["10.3389\/fmed.2022.1016198"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.1016198","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,12]]},"article-number":"1016198"}}